Cutaneous lupus erythematosus (CLE) is a rare autoimmune disease with a heterogeneous spectrum of clinical manifestations on the skin. Prof. Dr. med. Luca Borradori, Chief Physician and Clinic Director of Dermatology at Inselspital Bern, gave an up-to-date overview of the diagnostic clarifications to be carried out in the event of a clinical suspicion of CLE and the treatment options available. With adequate disease management, many CLE patients can maintain a good quality of life.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Chronic Pruritus in Renal, Hepatic, and Biliary Tract Diseases
Pooled Expertise for Targeted Evaluation and Treatment
- Advanced Thyroid Cancer
Molecular Mechanisms and New Therapeutic Approaches
- Epidermolysis bullosa
Promoting Wound Healing with Gene Therapies and Birch Bark Extract
- From Risk Identification to Anti-Inflammatory Intervention
Inflammation as a Treatment Goal in Its Own Right
- Psoriasis Research: What's in the Pipeline?
Highly selective oral TYK inhibitors in Phase III
- Cardiometabolism
Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon
- Pediatric Retinoblastoma
The Tumor Microenvironment and Modern Eye-Sparing Therapies
- Adherence and management in asthma and COPD